Claims for Patent: 8,030,064

Summary for Patent: 8,030,064

Title:	Method for whole surrounding surface display of target proteins using bacterial exosporium
Abstract:	The present invention relates to a method for expressing a target protein on an exosporium forming the outermost surface of bacterial spores. More particularly, the present invention relates to a method for expressing a target protein on the surface of cells and spores using an exosporium as a matrix for surface expression, and methods for the production of a protein array, the production of antibodies, the separation of a certain substance from a mixture, bioconversion, and the improvement of a target protein, which are characterized by using the cells or spores having the target protein that was expressed on the surface by the above expression method. The method for expressing the target protein on the surface of the spore outer membrane of the gene carriers according to the present invention has effects in that a variety of the target proteins can be expressed and the level of surface expression of the target protein is increased compared to the existing technology, and also the structural stability of the gene carriers having the target protein expressed on their surface, the viability of the host, and the rapidity of the screening method, are greatly increased.
Inventor(s):	Lee; Sang Yup (Daejeon, KR), Park; Tae Jung (Daejeon, KR), Park; Jong Pil (Yongin, KR), Lee; Seok Jae (Daejeon, KR), Pan; Jae-Gu (Chungcheongnamdo, KR), Jung; Heung-Chae (Deajeon, KR), Choi; Soo-Keun (Deajeon, KR)
Assignee:	Korea Advanced Institute of Science and Technology (Daejeon, KR) Genofocus, Inc. (Daejeon, KR)
Application Number:	10/572,224
Patent Claims:	1. A surface expression vector for use in a spore or cell, the vector comprising: a replication origin; an antibiotic-resistant gene; a restriction enzyme site; a gene encoding a protein of the exosporium selected from the group consisting of inhA isolated from Bacillus thuringiensis, bclA isolated from Bacillus anthracis, exsB, exsC, exsD, exsE, exsF, exsG, exsH, exsJ and exsY isolated from Bacillus cereus; and a gene encoding a target protein, wherein expression of the vector in the spore or cell results in expression of a fusion protein on the spore or cell surface, wherein the fusion protein comprises the exosporium protein and the target protein. 2. A recombinant bacterium which is obtained by transforming a bacterium selected from the group consisting of gram-negative bacteria and gram-positive bacteria with the expression vector of claim 1.

Details for Patent 8,030,064

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Emergent Biodefense Operations Lansing Llc	BIOTHRAX	anthrax vaccine adsorbed	Injection	103821	11/12/1998		2023-09-19